The effect of co-morbid anxiety on remission from depression for people participating in a randomised controlled trial of the Friendship Bench intervention in Zimbabwe. by Abas, Melanie Amna et al.
EClinicalMedicine 23 (2020) 100333
Contents lists available at ScienceDirect
EClinicalMedicine
journal homepage: https://www.journals.elsevier.com/eclinicalmedicineResearch PaperThe effect of co-morbid anxiety on remission from depression for people
participating in a randomised controlled trial of the Friendship Bench
intervention in Zimbabwe
Melanie Amna Abasa,b,*, Helen Anne Weissc, Victoria Simmsd, Ruth Verheye,
Simbarashe Rusakanikof, Ricardo Arayag, Dixon Chibandah,i
a King’s College London, Institute of Psychiatry, Psychology and Neuroscience, London, UK
b Centre for Anxiety Disorders and Trauma, South London and Maudsley NHS Foundation Trust, London, UK
cMRC Tropical Epidemiology Group, London School of Hygiene and Tropical Medicine, London, UK
dMRC Tropical Epidemiology Group, London School of Hygiene and Tropical Medicine, London, UK
e Research Support Centre, University of Zimbabwe, Harare, Zimbabwe
f Zimbabwe AIDS Prevention Project-University of Zimbabwe Department of Community Medicine, Harare, Zimbabwe
g King’s College London, Institute of Psychiatry, Psychology and Neuroscience, London, UK
h Research Support Centre, University of Zimbabwe, Harare, Zimbabwe
i Centre for Global Mental Health, London School of Hygiene and Tropical Medicine, London, UKA R T I C L E I N F O
Article History:
Received 28 October 2019
Revised 17 March 2020
Accepted 18 March 2020
Available online 27 May 2020* Corresponding author at: King’s College London, Inst
and Neuroscience, London, UK.
E-mail address:melanie.abas@kcl.ac.uk (M.A. Abas).
https://doi.org/10.1016/j.eclinm.2020.100333
2589-5370/© 2020 Published by Elsevier Ltd. This is an oA B S T R A C T
Background: There is a lack of data from low- and middle-income countries on whether anxiety indepen-
dently predicts a more chronic course for depression.
Methods: We undertook secondary data analysis of a cluster randomised controlled trial in Zimbabwe which
had tested the effectiveness of the Friendship Bench intervention for common mental disorders compared to
enhanced usual care. Inclusion for the current study was participants from the trial who had probable major
depression at baseline, defined as scoring => 11 on the locally validated Patient Health Questionnaire
(PHQ9). This emerged to be 354 of the original 573 (61.78%) of the original trial sample. Anxiety was mea-
sured using the locally validated cut-point on the Generalised Anxiety Disorder scale (GAD-7). Persistent
depression was defined as scoring => 11 on the PHQ-9 at six-months follow-up. Analysis in Stata 15 used
random-effects logistic regression to adjust for clustering by clinic.
Outcomes: Of the 354 participants who were eligible for treatment, 329 (92¢9%) completed 6-month follow-
up assessment. 37% of the trial sample had persistent depression at 6-months follow-up; 59% in the control
arm and 17% in the intervention arm. Co-morbid anxiety present at trial baseline was independently associ-
ated with persistent depression after adjusting for age, gender and baseline depression severity (adjusted
OR = 2¢83, 95% CI 1¢326¢07). There was no evidence of effect modification by trial arm. Baseline depression
severity also predicted persistent depression. Interpretation Treatment for depression in low and middle-
income countries (LMIC) should be directed towards those with greatest need. This includes people with co-
morbid anxiety and greater depression severity at initial assessment who are less likely to remit at six
months. Advice on coping with anxiety, psychological treatments which target common anxiety symptoms
such as fear, avoidance, excessive worry and intrusive thoughts, and Selective Serotonin Reuptake Inhibitors
(SSRIs) should be made more widely available in LMIC and offered to those with persistent mixed depression
and anxiety.
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pen access article under the CC BY-NC-ND license. (http://creativecommons.org/licenses/by-nc-nd/4.0/)1. Introduction
Depression is common worldwide with 4.4% of people estimated
to be affected at any given point in time, and 5.9% of women in Afri-
can countries [1]. Acute depression has received attention in low-
income countries [2,3] but there has been a lack of research on persis-
tent or recurrent depression. This is important because it is estimated
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months [4]. Longer episodes are important, being associated with
worse quality of life and predicting greater disability than shorter
episodes [5,6].
As more low-income countries develop policies to improve treat-
ment of depression in primary care [7,8], knowledge of which factors
predict a longer or shorter duration of depression, and of which fac-
tors predict more rapid response to treatment, would be helpful. Evi-
dence from systematic reviews of longitudinal population-based
studies, and from systematic reviews and meta-analyses of treatment
studies [9] show that patient-level factors predicting delayed remis-
sion include duration of current episode [10], a past history of
depression [11] and baseline depression severity [11], co-morbid per-
sonality disorder and substance use [4,11] and several socio-demo-
graphic factors including lower socioeconomic position [12], older
age, experience of child maltreatment [13] and less education [14].
All the studies included in these reviews were from high-income
countries. Symptoms of anxiety and depression are known to be
highly correlated [15]. Findings from the US STAR-D trial and a multi-
county European trial found anxiety to predict slower response to
depression treatment [16,17]. A systematic review found anxiety and
depression to have a bidirectional relationship, especially over
shorter periods, and reported that anxiety symptoms and disorders
predicted depression [18]. Few of the studies included in that review
were from middle or low-income countries and all were limited,
either because they relied on retrospective recall of anxiety [19], or
because they did not adjust for baseline depression when studying
the impact of anxiety in predicting depression [19,20]. There is a lack
of prospective data from low- income and middle-income countries
(LMICs) on whether anxiety independently predicts persistent
depression.
The aim of the current study is to assess the impact of co-morbid
anxiety on recovery from depression among primary care clinic
attenders taking part in a clinical trial for common mental disorders
in Zimbabwe.
We undertook a secondary data analysis of a cluster randomised
controlled trial (RCT) in primary care, evaluating the effectiveness of
the Friendship Bench intervention, a stepped care intervention for
depression and other common mental disorders [21]. The therapy
used in the Friendship Bench is individual problem-solving therapy,
which is derived from social problem-solving [22]. The trial showed
that the Friendship Bench was strongly associated with remission of
common mental disorders including depression and anxiety [21].
The primary hypothesis of this study is that, for participants in the
Friendship Bench trial with depression at baseline significant anxiety
at baseline (is associated with persistent depression at six-month fol-
low-up after controlling for baseline levels of depression severity and
other confounding variables.
2. Methods
2.1. Study setting and trial participants
The cluster RCT was conducted from 2013 to 2015 in Harare [23].
Twenty-four government primary health care clinics (clusters) were
randomised 1:1 to receive the Friendship Bench intervention or
Enhanced Usual Care (EUC). EUC comprised brief psychoeducation,
nurse-led evaluation for severe cases, and an option for antidepres-
sant medication. In the intervention clusters, participants were
offered six-sessions of Problem-Solving Therapy delivered on a
Friendship Bench as well as EUC.
The inclusion criteria for individual participants were screening
positive for common mental disorders (CMD) on the locally-devel-
oped and validated Shona Symptom Questionnaire (SSQ-14) [24] and
age 18 years or older. Participants completed the Patient Health
Questionnaire (PHQ-9) for depression and the Generalised AnxietyDisorder Assessment (GAD-7) for anxiety. Exclusion criteria were
persons who were unable to comprehend the nature of the study in
either English or Shona (local language), had suicidal intent, had end-
stage AIDS, were currently in psychiatric care, were pregnant or up to
three months’ postpartum, or presented with current psychosis,
intoxication, and/or dementia. Among 573 randomized patients (286
in the intervention group and 287 in the control group), 86% were
women with an average age of 33 years. 521 (91%) completed follow-
up at 6 months. Intervention group participants had fewer symptoms
of common mental disorders on the SSQ-14 than control group par-
ticipants (adjusted mean difference, 4.86; 95% CI, 5.63 to 4.10;
P < .001) and also lower risk of scoring above cut-point on the PHQ-9
for depression (13.7% vs 49.9%; P < .001).The protocol for the trial
was approved by the ethics committees of the Medical Research
Council of Zimbabwe and London School of Hygiene and Tropical
Medicine [21].
The current paper presents results of the secondary analysis of
trial participants who met criteria for probable major depression at
baseline.
3. Measures for the current study
3.1. Depression
The PHQ-9 has been used extensively and across many countries
in all world regions for screening and follow-up of depression. It con-
sists of nine items, based on the DSM-IV criteria for major depression,
and each item is rated on a four-point Likert-type scale [25]. The
maximum score is 27 indicating severe depression, and the minimum
is zero, zero meaning that the participant experienced no symptoms
of depression in the past two weeks. The PHQ-9 has been validated
against a diagnosis of major depression made using the Structured
Clinical Interview for DSM-IV (SCID) [24] in a primary care population
in Harare, Zimbabwe. A cut-point of 11 provided a sensitivity of
85%, specificity of 69%, and acceptable reliability (Cronbach’s a score
of 0¢86) in Harare with the area under the ROC curve of 0¢84 (95% CI
0¢790¢88). For analyses we used standard cutpoints of 1014 (mod-
erate), 1519 (moderately severe) and =20 (severe) depression
[26].
3.2. Anxiety
Our primary outcome measure was anxiety, as measured by the
GAD-7. The GAD-7 is a screening tool and severity measure for Gen-
eralised Anxiety Disorder (GAD) [26]. It consists of seven items with
four-point Likert-type scale responses coded in the same fashion as
the PHQ-9. The maximum score is 21 indicating severe anxiety, the
minimum 0. A score of 10 has been validated as sensitive (89%) and
specific (73%) against a SCID diagnosis of any anxiety disorder for a
Zimbabwean primary care population (Cronbach’s a = 087) [24].
The GAD-7 is often used as a general screening tool and symptom
severity measure for four common anxiety and stress-related disor-
ders including GAD, Panic Disorder, Social Anxiety, and Post-
Traumatic Stress Disorder [27].
3.3. Co-variables
Socio-demographic variables were measured through a locally
adapted questionnaire developed for similar studies previously con-
ducted in this setting [2831]. These studies found recent negative
life events, poverty and female gender to be associated with common
mental disorders. Younger age of onset of depression and less educa-
tion are associated with worse outcome so we wanted to test age and
education in our analyses. Adolescence is defined as up to the age of
24 [32,33]. Further variables such as age, marital status, religion, edu-
cation, employment, chronic illness, hazardous drinking, and
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in our analysis for a more comprehensive understanding of the socio-
demographic factors affecting anxiety and depression. Disability was
measured using theWorld Health Organization Disability Assessment
Scale (WHODAS), a generic assessment instrument measuring health
and disability through six domains in life (cognition, mobility, self-
care, getting along, life activities and participation). Higher scores on
the WHODAS indicate greater disability [34].
The Alcohol Use Disorder Identification Test (AUDIT) was used to
identify hazardous drinking. This ten-item five-point Likert-style
questionnaire is recommended by the WHO as a screening tool for
detecting alcohol use disorders internationally [35,36]. The WHO rec-
ommended score of 8 was used to define hazardous alcohol con-
sumption. HIV status was ascertained by self-report. Exposure to
negative life events in the previous six months was measured using a
Shona version of the Brief List of threatening events, adapted and
used for previous research in Zimbabwe [30].
3.4. Statistical analysis
Data were collected using tablet computers, uploaded to a secure
server using cloud computing technology and exported to Stata 14Table 1
Baseline factors associated with persistent depression, by trial arm.
Intervention arm
Baseline characteristic Total Persistent depression (%) Univariable
Total 172 30 (174%) 
Age group P = 0.17
1824 35 7 (20.0%) 1
2534 65 7 (10.8%) 0.48 (0.151
>=35 72 16 (22.2%) 1.14 (0.420
Sex   P = 014
Female 152 24 (158%) 1
Male 20 6 (300%) 229 (080
Religion   P = 003
Christian 161 25 (155%) 1
Other/none 11 5 (455%) 453 (128
Education   P = 097
<=Primary 98 17 (177%) 1
>=Secondary 74 13 (176%) 102 (046
Employment   P = 018
Unemployed 58 7 (121%) 1
Permanent employment 36 9 (250%) 243 (081
Casual/self 78 14 (180%) 159 (060
Go to sleep hungry   P = 072
No 114 19 (167%) 1
Yes 58 11 (190%) 117 (052
AUDIT score   P = 094
<8 160 28 (175%) 1
>=8 12 2 (167%) 094 (020
HIV status   P = 030
Negative 76 12 (158%) 1
Positive 72 11 (153%) 096 (039
Declined 24 7 (292%) 220 (075
Disability score   P = 0004
WHODAS <20 138 18 (130%) 1
WHODAS >=20 34 12 (353%) 363 (154
Depression score (PHQ-9)   P = 009
1014 (moderate) 70 7 (100%) 1
1519 (moderately severe) 70 16 (229%) 266 (102
2024 (severe) 32 7 (219%) 252 (080
Anxiety (GAD-7)   P = 008
GAD-7<10 46 4 (87%) 1
GAD-7>=10 126 26 (206%) 273 (090
Negative life events   P = 072
01 13 3 (231%) 1
24 85 13 (153%) 060 (015
5 or more 74 14 (189%) 078 (019for cleaning and analysis. The level of follow up was high (929%) and
we conducted a complete case analysis. All analyses for this paper
were conducted in Stata 15 using random-effects logistic regression
to adjust for clustering by clinic. Given that being in the intervention
arm was strongly associated with less persistent depression, analyses
of factors associated with persistent depression were stratified by
intervention arm. Variables associated with both baseline anxiety
(main exposure) and persistent depression (outcome) in one or both
arms were identified as potential confounders, and were included
(with baseline depression category, age and sex as a-priori specified
confounders), in an initial multivariable random effects logistic
regression model. Variables were retained if they acted as confound-
ers in this model by changing the crude odds ratio by 10% or more.
Effect-modification, between intervention arm and baseline anxiety,
for the effect of anxiety on depression, was assessed by fitting an
interaction term between baseline anxiety and intervention arm.
Sensitivity analysis were conducted using multiple imputation for
participants with missing outcome data. Endline depression data for
the individuals with missing data were imputed assuming data were
missing at random, using logistic regression adjusting for baseline
variables and for clustering by site as a fixed effect, using aug-
mented-regression to handle perfect prediction [37] and fiveEnhanced Usual Care arm
OR (95% CI) Total Persistent depression (%) Univariable OR (95% CI)
157 92 (586%) 
P = 0.24
19 14 (73.7%) 1
.51) 66 40 (60.6%) 0.54 (0.171.74)
.57) 72 38 (52.8%) 0.39 (0.121.25)
  P = 074
131 76 (580%) 1
654) 26 16 (615%) 117 (048286)
  P = 037
141 81 (575%) 1
1600) 16 11 (688%) 167 (053526)
  P = 017
98 62 (633%) 1
225) 59 30 (509%) 062 (031122)
  P = 022
67 41 (612%) 1
724) 29 20 (690%) 127 (047343)
424) 61 31 (508%) 059 (028126)
  P = 059
111 67 (604%) 1
266) 46 25 (544%) 082 (040169)
  P = 025
141 81 (575%) 1
454) 16 11 (688%) 196 (060635)
  P = 066
65 36 (554%) 1
234) 75 47 (627%) 137 (067277)
643) 17 9 (529%) 101 (033313)
  P = 026
129 73 (566%) 1
860) 28 19 (679%) 165 (068402)
  P = 00004
57 22 (386%) 1
696) 67 47 (702%) 402 (183886)
792) 33 23 (697%) 432 (1611157)
  P = 0001
31 9 (290%) 1
831) 126 83 (659%) 536 (2141341)
  P = 050
6 3 (500%) 1
249) 94 52 (553%) 124 (022689)
320) 57 37 (649%) 184 (0321054)
Table 2
Baseline factors associated with co-morbid anxiety disorder at baseline.
Baseline characteristic Total Anxiety (%) Univariable OR (95% CI)
Total 329 252 (766%) 
Sex   P = 014
Female 283 213 (753%) 1
Male 46 39 (848%) 183 (078430)
Age group   P = 031
1824 54 38 (704%) 1
2534 131 105 (802%) 176 (084371)
>=35 144 109 (757%) 134 (066272)
Marital status   P = 097
Married/cohabiting 209 161 (770%) 1
Divorced/separated/widowed 103 78 (757%) 094 (054164)
Single 17 13 (765%) 095 (029308)
Religion   P = 0003
Christian 302 226 (748%) 1
Other 27 26 (963%) 872 (116655)
Education   P = 064
<=Primary 196 149 (760%) 1
>=Secondary 133 103 (774%) 108 (064183)
Employment   P = 023
Unemployed 125 101 (808%) 1
Permanent employment 65 51 (785%) 087 (041183)
Casual/self-employed 139 100 (719%) 061 (034110)
Chronic illness   P = 100
No 239 183 (766%) 1
Yes 90 69 (767%) 100 (056179)
Go to sleep hungry   P = 052
No 225 170 (756%) 1
Yes 104 82 (789%) 120 (068211)
AUDIT score   P<0002
<8 301 224 (744%) 1
>=8 28 28 (100%) n/a
HIV status   P = 077
Negative 141 106 (752%) 1
Positive 147 115 (782%) 122 (069216)
Declined to say 41 31 (756%) 103 (046235)
Disability score   P = 005
WHODAS <20 267 199 (745%) 1
WHODAS >=20 62 53 (855%) 205 (095442)
Depression score   P<0001
1014 127 72 (567%) 1
1519 137 117 (854%) 449 (248815)
2024 65 63 (969%) 2414 (56510324)
Negative life events   P = 00006
01 19 10 (526%) 1
24 179 129 (721%) 232 (089605)
5 or more 131 113 (863%) 565 (2021581)
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model was checked using correlation matrix of coefficients in the
final regression model.
3.5. Role of the funding source
The funder had no role in data analysis or interpretation of results.
4. Results
4.1. Study participants
Recruitment took place from September to December 2014. A
total of 573 participants were enrolled into the original trial (287 in
the EUC arm and 286 in the intervention arm). This represents 85% of
those eligible to take part (100/673 refused) based on screening of
consecutive primary care attenders.[21] Of these, 354 (62¢0%) met
criteria for probable major depression at baseline (PHQ-9 9  11). Of
those who met the criteria, 186 were in the intervention arm and
168 in the EUC arm. Data on depression at six-month follow-up was
available for 329 (92¢9%) participants. Overall 122 (37¢1%) had persis-
tent depression at six months; 58¢6% in the control arm and 17¢4% in
the intervention arm. This also means that 41¢4% of the control arm
82¢6% in the intervention arm had remitted below PHQ-9 cut-point
at six months follow-up. Table 1 shows baseline factors associated
with persistent depression.
There was evidence from univariable analysis that baseline anxi-
ety and depression were associated with persistent depression
among participants in both arms (Table 1). The odds ratio for the
association for baseline anxiety and persistent depression in the
treatment arm was 2¢73 (95%CI 0¢908¢31) and in the EUC arm was
5¢36 (95%CI 2¢1413¢41). Having greater disability and being of non-
Christian religion, or having no religion, at baseline were associated
with persistent depression in the intervention arm only.
Prevalence of baseline co-morbid anxiety was high (76¢6%) and
co-morbid anxiety was associated with non-Christian religion, base-
line AUDIT score, greater disability and depression score, and number
of negative life events. Specifically, the following recent life events
were associated with anxiety: loss of accommodation, divorce,
domestic upheaval, experience of violence (Table 2). Religion, greater
disability and depression score were included as potential confound-
ers in the multivariable model.
As shown in Table 3, there was evidence of an association
between baseline anxiety and persistent depression after adjustment
for confounders (adjusted OR = 2¢83, 95%CI 1¢326¢07). There was no
evidence of effect modification by arm in the multivariable model
(interaction OR = 0¢58, 95%CI 0¢132¢51) so, as shown in Table 3, the
final model includes data for both arms. Results were similar using
multiple imputation for the 25 participants with missing outcome
data on persistent depression (adjusted OR = 2.87, 95%CI 1.306.30).
There was little evidence of collinearity between coefficients in the
multivariable regression model (results not shown).
5. Discussion
We carried out secondary analysis of data from a clinical trial of
the Friendship Bench intervention for common mental disorders in
Zimbabwe. The active intervention mainly consisted of individual
problem-solving therapy delivered on a bench by a grandmother lay
worker and the control comprised brief psychoeducation. Of those
who met criteria for probable major depression at trial baseline, 59%
in the control arm and 17% in the intervention arm had persistent
depression at six-month follow-up. We found that significant anxiety
at trial baseline, defined as GAD-7 score above validated cut-point for
generalised anxiety [21], was an independent predictor of persistent
depression, and that the effect of anxiety was present in both theintervention arm and the enhanced usual care arm. As far as we
know this is the first report of this finding from a low-income coun-
try. This is in keeping with evidence from a systematic review of lon-
gitudinal studies, mainly from high-income countries, which found
anxiety symptoms and disorders (including post-traumatic stress dis-
order) to predict depression symptoms and depressive disorders [18]
and with major clinical studies in high-income countries including
the STAR-D trial [17] which have found anxiety to predict slower
response to depression treatment [16]. We found that depression
severity at baseline was also an independent predictor for persistent
depression at six-month follow-up, as has been clearly shown in a
systematic review of studies from HIC [4].
There are several reasons why a high score on the GAD-7 may pre-
dict persistent depression in this setting. Firstly, mixed generalised
anxiety and depression might best be conceptualized as manifesta-
tions of a single underlying syndrome. Indeed, the cultural idiom
linked mostly closely to depression in Zimbabwe, and in several other
African countries, is “thinking too much” [38]. A systematic review of
this symptom, or expression, found that in some cultural settings it
seemed to indicate a broader syndrome of depression which included
a mixture of anxiety symptoms [39]. However, against this view of
GAD being part of major depression are differences in risk factors for
Table 3
Multivariate association of baseline characteristics with persistent depression.
Baseline characteristic Total Persistent depression
(%)
Adjusted OR (95% CI)
Anxiety   P = 0007
GAD-7<10 77 13 (169%) 1
GAD-7>=10 252 109 (433%) 283 (132607)
Arm   P<0001
EUC 157 92 (586%) 1
Intervention 172 30 (174%) 012 (007022)
Age group   P = 027
1824 54 21 (389%) 1
2534 131 47 (359%) 052 (024116)
>=35 144 54 (375%) 058 (0271.26)
Sex   P = 033
Female 283 100 (353%) 1
Male 46 22 (478%) 128 (058281)
Religion   P = 017
Christian 302 106 (351%) 1
Other 27 16 (593%) 199 (074529)
Depression score   P = 002
1014 127 29 (228%) 1
1519 137 63 (460%) 243 (128460)
2024 65 30 (462%) 182 (082405)
Disability score   P = 004
WHODAS <20 267 91 (341%) 1
WHODAS >=20 62 31 (500%) 211 (105423)
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A different way to understand this is that the fear and sense of threat
which characterise anxiety and stress-related disorders tend to pro-
voke avoidance, whereas lack of interest and slowing in depression
tends to lead to social withdrawal. Avoidance and withdrawal could,
through separate pathways, both contribute to persistent depression
through failure to deal with difficult problems and through self-
denial of activities which might have given a sense of achievement
and thus aided recovery. A further consideration is that trauma expe-
riences are common in people using primary care in low-income
countries including Zimbabwe, and past trauma may have worsened
depression recovery [42,43]. The GAD-7 scale may have been detect-
ing anxiety as part of post-traumatic stress disorder which is known
to predict persistent depression in primary care in HIC [44].
One limitation of this study is that measurement of anxiety and of
depression relied on screening scales rather than diagnoses. How-
ever, we had validated the GAD-7 and the PHQ-9 and found they had
good psychometric properties against diagnoses made using the SCID
[21]. Another limitation is that we define severity of depression by
adding up the scores for individual depressive symptoms. However,
individual symptoms may not have different weights in the manifes-
tation of severity of depression and increasingly depression is being
viewed as a heterogenous disorder [45]. Another limitation is the fol-
low-up of only six months. A longer follow-up period (e.g. one year)
would allow for a better understanding of the long-term effects of
the intervention on persistent depression. Strengths of the study,
which support generalisability to other countries in the region, is
that the study sample came from screening consecutive government
primary care clinic attenders, and 85% of those meeting inclusion cri-
teria took part. The evidence for the impact of baseline anxiety on
worse depression outcome was strong at p < 0¢001.
These findings from Zimbabwe add to the global evidence that co-
morbid anxiety is an independent predictor of persistent depression
[11,46,4,18,19]. Treatment for depression in LMIC should be directed
towards those with greatest need, including those with more anxiety
symptoms and greater depression severity at initial assessment. Fur-
ther research is needed to explore whether high GAD scores in LMIC
indicate anxiety disorders, such as panic disorder, social anxiety or
generalised anxiety, or instead indicate trauma and stress related dis-
orders such as PTSD as these would benefit from different treatmentapproaches. Many of the psychological treatments being advocated
for use in resource-limited settings, such as problem-solving therapy
[47] and interpersonal therapy [48], while improving common men-
tal disorders, do not specifically target fear, avoidance, excessive
worry, and re-living of trauma experiences. Such treatments would
include psychoeducation about coping with anxiety, self-help cogni-
tive behavioural therapy, relaxation-training, exposure-based ther-
apy, and serotonin-re-uptake inhibitors. More research is needed to
increase access worldwide to key components of low-intensity evi-
dence-based psychological therapies for anxiety disorders, for
instance by task-shifting culturally adapted therapies based on expo-
sure to feared situations and to reducing avoidance [49]. In contrast,
for those with mild depression and little or no anxiety who present
for care in LMIC, active monitoring composing brief psychoeducation
and an arrangement to review in two weeks would seem justifiable





Part of the intervention trial data can be found at http://datacom
pass.lshtm.ac.uk/455/. Further information can be obtained by Dr.
Victoria Simms at Victoria.simms@lshtm.ac.uk.
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